The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rouyez, M.-C.
Right arrow Articles by Dusanter-Fourt, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rouyez, M.-C.
Right arrow Articles by Dusanter-Fourt, I.
The Journal of Immunology, 2005, 174: 3948-3958.
Copyright © 2005 by The American Association of Immunologists

IFN Regulatory Factor-2 Cooperates with STAT1 to Regulate Transporter Associated with Antigen Processing-1 Promoter Activity1

Marie-Christine Rouyez*, Marta Lestingi*, Martine Charon*, Serge Fichelson*, Agnès Buzyn{dagger} and Isabelle Dusanter-Fourt2,*

Departments of * Hematology and {dagger} Immunology, Institut Cochin, Paris, France

Class I MHC complexes (MHCI) are essential in mediating immune response. The transport of antigenic peptides (TAP) to MHCI and the stable expression of MHCI on the cell surface require the presence of a dedicated TAP. In this study we report that IFN-{gamma} and thrombopoietin (TPO) strongly increase TAP1 protein expression in megakaryocytes, followed by an enhanced expression of MHCI on the cell surface. This expression parallels the enhanced TAP1 promoter activity and TAP1 mRNA expression, which are independent of protein synthesis. We also show that this cytokine-dependent expression of TAP1 transcripts depends on STAT1 and IFN regulatory factor-2 (IRF-2), but not on IRF-1, and provide evidence that IRF-2 constitutively binds to the TAP1 gene promoter and enhances TAP1 promoter activity. We show that IRF-2 forms a complex with STAT1 and the cytokine-responsive region of the TAP1 promoter in any TPO or IFN-{gamma} target cells tested. Interaction of IRF-2 and STAT1 on the promoter depends on the DNA-binding domain of IRF-2. Overall, our data indicate that TPO and IFN-{gamma} activate the expression of TAP1 via a new mechanism that involves functional cooperation between STAT1 and IRF-2 on the TAP1 promoter.




This article has been cited by other articles:


Home page
BioinformaticsHome page
J. Smieja, M. Jamaluddin, A. R. Brasier, and M. Kimmel
Model-based analysis of interferon-{beta} induced signaling pathway
Bioinformatics, October 15, 2008; 24(20): 2363 - 2369.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Wang, D. Liu, P. Chen, H. P. Koeffler, X. Tong, and D. Xie
Negative Feedback Regulation of IFN-{gamma} Pathway by IFN Regulatory Factor 2 in Esophageal Cancers
Cancer Res., February 15, 2008; 68(4): 1136 - 1143.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Schroder, M. Spille, A. Pilz, J. Lattin, K. A. Bode, K. M. Irvine, A. D. Burrows, T. Ravasi, H. Weighardt, K. J. Stacey, et al.
Differential Effects of CpG DNA on IFN-beta Induction and STAT1 Activation in Murine Macrophages versus Dendritic Cells: Alternatively Activated STAT1 Negatively Regulates TLR Signaling in Macrophages
J. Immunol., September 15, 2007; 179(6): 3495 - 3503.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. Wang, H. D. Edington, U. N.M. Rao, D. M. Jukic, S. R. Land, S. Ferrone, and J. M. Kirkwood
Modulation of Signal Transducers and Activators of Transcription 1 and 3 Signaling in Melanoma by High-Dose IFN{alpha}2b
Clin. Cancer Res., March 1, 2007; 13(5): 1523 - 1531.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. M. Tooze, S. Stephenson, and G. M. Doody
Repression of IFN-{gamma} Induction of Class II Transactivator: A Role for PRDM1/Blimp-1 in Regulation of Cytokine Signaling
J. Immunol., October 1, 2006; 177(7): 4584 - 4593.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.